Recruiting

Single Port Endoscopic Breast Conserving Surgery

The center plans to carry out a prospective clinical study of single hole total endoscopic breast conserving surgery for early breast cancer compared with open breast conserving surgery, to provide high-level evidence-based medical evidence for the development of endoscopic breast conserving surgery for early breast cancer.

ClinicalTrials.gov IDNCT06593132

PhaseNot Applicable

Enrollment200

SponsorRen,Yu

Age20 Years

SexFEMALE

I'm interested View official listing

Conditions studied

Breast Conserving Surgery, Endoscopic Surgery

About this study

Interventions

Procedure: endoscopic breast conserving surgery — Breast endoscopy technology completes complex surgical operations through small incisions, achieving aesthetically pleasing results while ensuring tumor safety.

Primary outcomes

Six months after operation SURVIVAL EFFECTS (From enrollment to the end of 6 months after surgery)

Eligibility information

Inclusion Criteria: 1. Breast cancer confirmed by pathology； 2. Tumor \<5 cm, TNM stage 0-II； 3. Single Port Endoscopic or traditional open surgery; (4)20 to 70 years old female patients. Exclusion Criteria: 1. Bilateral breast cancer; 2. Reconstruction after breast conserving surgery ; 3. Basic information is not complete； 4. Breast conserving surgery was converted to modified radical resection or subcutaneous adenoidectomy.

Study locations

the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061 China

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.